Compounding Pharmacy · Largo, FL · 503B

BPI Labs Review

Largo, Florida. Belcher Pharmaceuticals owns it, and FDA registers it both as a drug manufacturer and as a 503B outsourcing facility. Injectable semaglutide and tirzepatide were made here at scale for telehealth brands, Hims & Hers among them. That stopped voluntarily around April 2026, as FDA moved to strike both molecules from the 503B bulk-drug list.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

503BFDA-registered 503B outsourcing facilityFDA-registered drug manufacturer
Location: Largo, FL
Website: bpilabs.com
States licensed: 0
6.0
★★★☆☆3/5

Our own score · methodology

Telehealth Brands That Fill Through This Pharmacy

Each brand below has been reported to route some or all of its compounded GLP-1 orders to BPI Labs. Arrangements like these are commercial, and they get changed without announcement.

8.4/ 10

GobyMeds

Best for: moving between compounded and brand without changing seller

★★★★4.2/5

Editorial score · methodology

$93/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full GobyMeds review →
8.3/ 10

Belle Health

Best for: semaglutide at $119/month, 37% under the register median

★★★★4.2/5

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideLegitScript VerifiedFDA Warning
Get StartedRead full Belle Health review →
6.8/ 10

Hims

Best for: knowing which pharmacy fills the vial — it names Apostrophe Pharmacy LLC

★★★☆☆3.4/5

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full Hims review →
6.6/ 10

Hers

Best for: coverage in all 50 states, which most of the register will not confirm

★★★☆☆3.3/5

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full Hers review →

GLP-1 Partners We Score Highest

None of these fill through BPI Labs. They are the compounded GLP-1 partners at the top of our own scoring, here in case you would rather start with a service we have taken through signup ourselves.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.9

Oak

Semaglutide at $119/month, 37% under the register median

Starting price: $119/mo

Get started →Read review Oak
6.5

Direct Meds

Compounded semaglutide at $249/month

Starting price: $249/mo

Get started →Read review Direct Meds
8.8

Found

Tirzepatide at $169/month, 37% under the register median

Starting price: $99/mo

Get started →Read review Found
7.7

Breeze Meds

Knowing which pharmacy fills the vial — it names Belmar Pharmacy

Starting price: $199/mo

Get started →Read review Breeze Meds

Accreditations and Standards

Sterile compounding in this country runs on one rulebook, General Chapter <797> of the United States Pharmacopeia[4]. Depending on what is being made, the finished preparation is then tested for sterility under USP <71>[5] and for bacterial endotoxins under USP <85>[6]. Every pharmacy on this page owes those standards already. What follows is what this one has added on top.

FDA-registered 503B outsourcing facility
The facility appears on the FDA's own register as a 503B outsourcing facility. That listing brings it inside the FDA's inspection remit and holds it to cGMP.
FDA-registered drug manufacturer
A further credential the pharmacy discloses about itself.

What It Compounds

Whether any pharmacy may compound semaglutide or tirzepatide at all turns on where the reference product sits on the FDA Drug Shortage List. When a drug comes off that list the door closes, and it has closed before[7].

Semaglutide
Compounds semaglutide
Tirzepatide
Compounds tirzepatide

States Licensed

BPI Labs publishes no state-by-state licensure list, so we cannot tell you whether it is licensed where you live. Put that question to your own state board of pharmacy before you fill anything here.

What Regulators Have on File

2026-04
Voluntarily ceased compounded semaglutide and tirzepatide production amid the FDA's move to exclude GLP-1s from the 503B bulks list.

How GLP Watchdog Scored This Pharmacy

Accreditation held6/10
Standing with regulators5/10
States licensed0/10
GLP-1 compounding10/10
Years operating5/10

We research every score ourselves. The methodology page sets out how each part is weighted.

High confidence · Last verified 2026-07-16 via research · How we check provider data

Frequently Asked Questions

Glossary

The words sellers use, defined. Tap any term.

Sources & methodology — as of August 2026
  1. 1.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and RequirementsU.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile PreparationsUnited States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility TestsUnited States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins TestUnited States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.